London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
EGTP, exactly! There seems to be communal amnesia on this board that the antigen test was hailed as THE way to tell whether the person you were sitting next to was Covid +ve or not. Given the choice between having your loved ones cared for by an untested but double vaccinated person versus one who was negative that day with AffiDX, who would you choose? No brainer.
"How does this work with regard to the Medusa19 exclusivity agreement. Calibre is non-exclusive but Medusa have pretty much global exclusivity unless Medusa and Avacta are negotiating deals jointly...house accounts etc"
Medusa has an exclusive licence for self-test and a non-exclusive licence for professional use (the same as Calibre).
The best simplest and cheapest way to lower the rising rate of hospitalisations in the Uk, Eu and ROW is to contain or at slow down the spread of the virus.
Anti bodies do not last and Guarantee nothing, so for the foreseeable future no vaccines will ever completely address this, and expensive part cures like the one SNG are developing will never play any major part in containing the current covid strain and future mutations.
I and every well informed person I speak with couldn’t care less about antibodies and whether the person they are sitting next too has a vaccine certificate, they just need to know they won’t catch the virus from them - just like some in the past didn’t want to sleep with someone HIV positive
The covid lft market is still enormous (granted there are many players now), and it would only require a vaccine busting variant to return us back to square one. On the other hand, if the mutations have now reached some kind of evolutionary cul-de-sac, then things will start to return to normal, and in my view fairly rapidly. At such a point Avacta dx can shift their focus to the other tests in their pipeline, such as stress, sepsis etc.
Knotagain I don't think that's true when you say "the only way out of this mess is for quality testing to be used alongside the vaccines."
Its ALL about outcomes. If vaccines stop national health services s being over whelmed and antivirals can maybe stop people being admitted to hospital or reducing their stay upon admittance to levels that are socially acceptable, then testing becomes largely irrelevant.
There is always going to be a demand for testing in some capacity but I think it will be a lot smaller than we expect (even now) and now of course the market is crowded in a way we never envisaged at the beginning.
The way you talk AgentB it's as if there are no Lateral Flow Tests being used, an LFT and a Vaccine are so different, it's ridiculous to suggest that one could be used INSTEAD of the other. Vaccines aren't perfect and neither are LFT's but to suggest there is a conspiracy is crazy. Yes there has been favouritism/corruption by handing contacts to friends and supporters of the Conservative party, but Avacta have been slow getting things out the door as well.
Unfortunately the Government shot their bolt with Innova. To have confidence in another test (AffiDX) it has to have a good track record as level playing field is order of the day. Good sales data for our LFD will be a vote of confidence.
Yes it’s frustrating as to why the market cannot be officially updated to what Medusa and Abingdon are already doing, because any determined columbo could find out this information anyway.
Obviously Medusa are a private company so have no need to say anything to anyone especially while sensitive price wise trade deals are been negotiated, but Abingdon should have a price sensitive reason for all the new recruitments whether they are paying them to work, or to just stand idle ;-)
@Pic How can you tell whether a vaccinated person is nearing the end of their immunity cycle or has just been boosted? How can you tell whether they are actually carrying Covid (because they can, you know)? As Alastair Smith told us from the outset (and we all believed before the brainwashing started) an accurate antigen test measures current infectiousness. As such, evidence of a recent negative test is much more reassuring than evidence of vaccination.
"The news blackout is not due to NDA but to ‘Trusted News Initiative’ which silences any alternative to the jab. I keep telling you all, we will hear plenty from the media when/if LFTs fit the Gov agenda."
You really are down the rabbit hole aren't you AgentB, if you think a cheap diagnostic test is an alternative to a vaccine you really are dumb. Give it a rest mate, almost no one is buying your conspiracy nonsense because it's, well it's nonsense
This is from the Aug LFT RNS update... 'The Company has recently appointed Calibre Scientific, a global distributor of diagnostic and life science products, as the first distributor for the test in the UK and European Union, and is progressing multiple commercial opportunities with distributors and end users in Europe, UK, Asia and elsewhere.'
How does this work with regard to the Medusa19 exclusivity agreement. Calibre is non-exclusive but Medusa have pretty much global exclusivity unless Medusa and Avacta are negotiating deals jointly...house accounts etc
gje306...you missed off supply chain issues. The kits are made up of all sorts of bits and pieces and one missing bit or items not coming through in sufficient volume will have an effect on either manufacturing assembly or finished product packaging.
The news blackout is not due to NDA but to ‘Trusted News Initiative’ which silences any alternative to the jab. I keep telling you all, we will hear plenty from the media when/if LFTs fit the Gov agenda.
A few possibilities have popped into my mind recently:
1. They can't get the cost of good competitive enough 2. Abbingdon are having difficulties scaling to the levels required for a pandemic and at the same time maintaining product consistency - which would fit with the comment about having to check the batches 3. Still no RNS worthy contracts, even if the product is shipping in smaller batch sizes 4. Everything is hunky-dory, we are selling to the NHS via the microbiology framework and via calibre, but none of it is considered RNS worthy, or Avacta have made the decision not to give a blow by blow account. 5. The next RNS'able news in AS's mind is the HUA approval.
I can't see Affidx being particularly difficult to manufacture relative to any other LFT, there is really nothing special about it.
"ABDX confirming they are now up to speed with Affidx"
Just how long does it take to do the validation on the 3 test runs? It is now FOUR WEEKS since AS said validation would start the following week. The time taken before 30 September (for how many months was TT being carried out?), the silence about this, and the lack of announcements of other manufacturers lead me to think that AffiDX is not an easy product to make and other manufacturers just don't want to get involved.